Please login to the form below
Eisai
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Eisai's 2012 sales performance.
Biogen to acquire Reata for approximately $7.3bn
The deal comes just a few weeks after Biogen and Eisai’s jointly developed Alzheimer’s disease drug was granted traditional approval in the US for use in patients with mild
Biogen/Eisai’s Alzheimer’s disease drug shows promise as a subcutaneous formulation
Biogen and Eisai’s Alzheimer’s disease drug has shown promise as a subcutaneous (SC) formulation, according to new data presented by Eisai at this year’s Alzheimer’s Association International
BMS obtains global rights to Prothena’s Alzheimer’s drug in deal worth $2.2bn
Earlier this month, Biogen and Eisai’s Alzheimer’s disease drug Leqembi was granted traditional approval by the US Food and Drug Administration, making it the first and only approved
Biogen/Eisai’s Alzheimer’s disease drug granted full FDA approval
In a very welcome move, Biogen and Eisai’s Alzheimer’s disease drug has been granted traditional approval by the US Food and Drug Administration (FDA). ... Eisai’s supplemental biologics application for approval under the traditional pathway was
Biogen/Eisai’s Alzheimer’s drug backed by FDA advisory committee for traditional approval
Biogen and Eisai’s Alzheimer’s disease drug has been recommended for traditional approval by a US Food and Drug Administration (FDA) panel of experts. ... Eisai’s supplemental biologics application for approval under the traditional pathway is
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
Six Degrees Medical Consulting
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
